Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Frontiers in Bioscience (Scholar Edition)|May 12, 2015
Twenty years of modelling NPM-ALK-induced lymphomagenesisSylvie Giuriato, Suzanne D TurnerCell Cycle (Georgetown, Tex.)|July 10, 2003
How cancers escape their oncogene habitSylvie Giuriato, Dean W FelsherCells|October 23, 2021
The Dual Role of Autophagy in Crizotinib-Treated ALK<sup>+</sup> ALCL: From the Lymphoma Cells Drug Resistance to Their DemiseEstelle Espinos, Raymond Lai, Sylvie GiuriatoCancers|December 1, 2017
Targeting Autophagy in ALK-Associated CancersJulie Frentzel, Domenico Sorrentino, Sylvie GiuriatoMedecine Sciences : M/S|April 4, 2017
[The yin and the yang of autophagy in cancer cells]Carine Joffre, Mojgan Djavaheri-Mergny, Sophie Pattingre, et al.Cells|February 2, 2019
Therapeutic Modulation of Autophagy in Leukaemia and LymphomaMojgan Djavaheri-Mergny, Sylvie Giuriato, Mario P Tschan, et al.Biochemical and Biophysical Research Communications|July 31, 2002
SHIP2 overexpression strongly reduces the proliferation rate of K562 erythroleukemia cell lineSylvie Giuriato, Daniel Blero, Bernard Robaye, et al.Seminars in Cancer Biology|February 6, 2004
Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancerSylvie Giuriato, Karen Rabin, Alice C Fan, et al.The Journal of Experimental Medicine|December 7, 2005
Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fatesEmmanuelle Passegué, Amy J Wagers, Sylvie Giuriato, et al.Blood|January 9, 2003
Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocationsAsa Karlsson, Sylvie Giuriato, Flora Tang, et al.Pageof 3